RI
NAUT icon

RTW Investments’s Nautilus Biotechnolgy NAUT Stock Holding History

RTW Investments’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-600,000
Closed -$1.08M – 69
2022
Q4 		$1.08M Hold
600,000
– – 0.02% 74
2022
Q3 		$1.27M Sell
600,000
-500,000
-45% -$1.26M 0.03% 83
2022
Q2 		$2.96M Hold
1,100,000
– – 0.08% 91
2022
Q1 		$4.77M Hold
1,100,000
– – 0.1% 80
2021
Q4 		$5.7M Hold
1,100,000
– – 0.08% 92
2021
Q3 		$6.59M Hold
1,100,000
– – 0.1% 86
2021
Q2 		$10.4M Buy
1,100,000
+600,000
+120% +$6.5M 0.16% 72
2021
Q1 		$6.89M Hold
500,000
– – 0.11% 80
2020
Q4 		$5.42M Hold
500,000
– – 0.09% 81
2020
Q3 		$5.41M Buy
+500,000
New +$5.33M 0.13% 81

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $473M AUM 49.24% 1-Year Est. Return

RTW Investments's NAUT Position: Q1 2023 in Review

RTW Investments sold out of Nautilus Biotechnolgy (NAUT) in Q1 2023, closing a stake of 600,000 shares — an estimated $1.08M sold.

RTW Investments first reported a position in NAUT in Q3 2020 and held it in 10 quarters. The position peaked at $10.4M in Q2 2021. 73 funds tracked by Wall St. Rank hold NAUT as of Q1 2023.

  • RTW Investments reported no remaining Nautilus Biotechnolgy position as of Q1 2023 after selling out during the quarter.
  • RTW Investments sold 600,000 Nautilus Biotechnolgy shares in Q1 2023, an estimated $1.08M.
  • RTW Investments first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 10 quarters.
  • RTW Investments's Nautilus Biotechnolgy position peaked at $10.4M in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2023.

Based on RTW Investments's 13F filing for Q1 2023, filed 15 May 2023.